Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,122 of 1,311 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,744 total, page 26 of 35
Acupuncture for Sleep Disruption in Cancer Survivors
NCT01162018
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
NCT01322971
Management of Insomnia in Breast Cancer Patients
NCT01011218
A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects
NCT01591148
Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates
NCT01357369
Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits
NCT01466751
Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT01401322
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
NCT01284504
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
NCT01151761
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
NCT01290484
Stanford Universities: The Stanford HIV Aging Cohort
NCT01401348
Imaging and Biomarkers of Hypoxia in Solid Tumors
NCT01123005
The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses
NCT01406795
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
NCT01187446
Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss
NCT01325805
Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human Volunteers
NCT01006707
Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery
NCT01245595
Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Cesarean Delivery
NCT01416454
Promoting Healthy Lifestyles Using Mobile Phones
NCT01516411
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
NCT01383135
A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
NCT01335113
Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents
NCT01217840
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)
NCT01507948
Environmental Strategies & Behavior Change to Reduce Overeating in Obese Children
NCT01221220
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
NCT01400269
Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
NCT01831934
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
NCT01423201
T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020
NCT01911065
Continuous Glucose Monitor Use in School
NCT01364766
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
NCT01450683
Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
NCT00721539
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
NCT01163526
A National Study of the Chronic Disease Self-Management Program
NCT01845857
Understanding and Diagnosing Allergic Disease in Twins
NCT01613885
Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
NCT01155817
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
NCT01182155
Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
NCT01114282
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
NCT01188486
Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes
NCT01186276
Pivotal Response Group Treatment for Parents of Young Children With Autism
NCT01881750
Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?
NCT02007577
Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections
NCT01200875
Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS)
NCT01171794
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
NCT01186250
Endogenous Endophthalmitis in the Inpatient Setting
NCT01323868
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
NCT01305252
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
NCT01165775
The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging
NCT01172041
Cyberknife Radiosurgery and Quality of Life
NCT01163539
Radiosurgical Neuromodulation for Refractory Depression
NCT01403441
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Stanford University: open-pipeline peers nationwide
Peers matched on 1,744 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Stanford University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,744 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- University of California, San Francisco · 1,713 trials · 16% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Baylor College of Medicine · 15% recruiting · 616 trials
- Wake Forest University Health Sciences · 15% recruiting · 1,140 trials
Related
What to do with this Stanford University page
1,744 registered trials is a research-attention snapshot, not an endorsement of Stanford University or any single study.
- 264 of Stanford University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Stanford University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Stanford University pipeline card: 1,744 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.